MedFiz@Online

MedFiz@Online
Referanslar
[1]. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
(2011) Effects of radiotherapy after breast-conserving surgery
on 10-year recurrence and 15-year breast cancer death: meta
-analysis of individual patient data for 10801 women in 17
randomized trials. Lancet 378: 1707-1716.
[2]. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher
ER, Jeong JH, Wolmark N.et al (2002) Twenty-year followup
of a randomized trial comparing total mastectomy, lumpectomy,
and lumpectomy plus irradiation for the treatment
of invasive breast cancer. N Eng J Med 347: 1233-1241.
[3]. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V,
Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, et al.
(1993) Radiotherapy after breast-preserving surgery in women
with localized cancer of the breast. N Eng J Med 328: 1587
-1591.
[4]. Theberge V, Whelan T, Shatelman SF, Vicini F (2011) Altered
fractionation: Rationale and justification for whole and partial
breast hypofractionated radiotherapy. Semin Radiat Oncol
21: 55-65.
[5]. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den
Bogaert W. (1990) Time-dose factors in radiotherapy: A review
of the human data. Radiother Oncol 19: 219-235.
[6]. Williams MV, Denekemp J, Fowler JF (1985) A review of α/β
ratios for experimental tumors: Implications for clinical studies
of altered fractionation. Int J Radiat Oncol Biol Phys 11: 87
-96.
[7]. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J,
Haviland J, Bentzen S, Owen R (2005) Fractionation sensitivity
and dose response of late adverse effects in the breast after
radiotherapy for early breast cancer: Long-term results of a
randomized trial. Radiother Oncol 75: 9-17.
[8]. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson
J, Haviland J, Bentzen S, Yarnold J (2006) Effect of radiotherapy
fraction size on tumor control in patients with early-stage
breast cancer after local tumor excision: long-term results of
a randomized trial. Lancet Oncol 7: 467-471.
[9]. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard
L, Lada B, Lukka H, Perera F, Fyles A, Laukkanen E, Gulavita S,
Benk V, Szechtman B. (2002) Randomized trial of breast irradiation
schedules after lumpectomy for women with lymph
node-negative breast cancer. J Natl Cancer Inst 94: 1143-
1150.
[10]. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation
Therapy Oncology Group (RTOG) and the European Organization
for Research and Treatment of Cancer (EORTC). Int
J Radiat Oncol Biol Phys 31: 1341–1346.
[11]. The START Trialists’ Group (2008): The UK Standardization of
Breast Radiotherapy (START) Trial A of radiotherapy
hypofractionation for treatment of early breast cancer: a randomized
trial. Lancet Oncol 9: 331-341.
[12]. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett-Lee PJ,
et al (2013) The UK Standardization of Breast Radiotherapy
(START) trials of radiotherapy hypofractionation for treatment
of early breast cancer: 10-year follow-up results of two
randomized controlled trials. Lancet Oncol 14: 1086-1094.
[13]. The START Trialists’ Group (2008): The UK Standardization of
Breast Radiotherapy (START) Trial B of radiotherapy
hypofractionation for treatment of early breast cancer: a randomized
trial. Lancet 371: 1098-1107.
[14]. The FAST Trialists Group (2011) First results of the randomized
UK FAST Trial of radiotherapy hypofractionation for
treatment of early breast cancer (CRUKE/04/015). Radiother
Oncol 100: 93-100.
[15]. Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA (2001)
The role of biologically effective dose (BED) in clinical oncology.
Clin Oncol 13: 71-81.
[16]. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E,
Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P,
McHugh T, Peto R, Taylor C, Wang Y; Early Breast Cancer
Trialists' Collaborative Group (EBCTCG) (2005) Effects of radiotherapy
and of differences in the extent of surgery for early
breast cancer on local recurrence and 15-year survival: an
overview of the randomized trials. Lancet 366: 2087-2106.
[17]. Journal Club (2010) Are Three Weeks of Whole-Breast
Radiotherapy as Good as Five Weeks in Early Breast Cancer? -
10 Year Follow-Up in the Canadian Trial of Hypofractionated
Radiation Therapy. Breast Care (Basel). 5: 272-274.
[18]. NCCN Guidelines, Version 2.2016.
Prof.Dr. Füsun TOKATLI
1985 yılında İstanbul Üniversitesi Tıp Fakültesinden mezun olmuştur. Radyasyon
Onkoloğu olarak 1991 yılında Şişli Etfal Hastanesinden uzmanlığını aldıktan sonra 1992
-1993 yılları arasında Londra’da Guy’s Hastanesi Radyoterapi departmanında çalışmıştır.
1993-2000 yılları arasında Vakıf Gureba Hastanesinde başasistan olarak çalışan Dr.
Tokatlı, 2000 yılında Trakya Üniversitesinde yardımcı doçent, 2006 yılında Doçent
unvanını almıştır. Türk Radyasyon Onkolojisi Derneği, Avrupa ve Amerikan Radyasyon
Onkolojisi derneklerine üyedir. Ellinin üzerinde orjinal yurtiçi ve yurtdışı yayınlanmış
makalesi, 100’ün üstünde poster sunumları, yurtiçi üç kitap bölümü, bir yurtdışı kitap
bölümü yazarlığı ve oturum başkanlıkları vardır. Çalışmalarına 300’ün üzerinde atıf yapılmış olup, çalışmaları nedeniyle
almış olduğu üç ödülü bulunmaktadır. İngilizce bilen Dr.Tokatlı’nın bir oğlu vardır. 2008 yılından beri Medicana
International İstanbul Hastanesi Radyasyon Onkolojisi ünitesinin başkanı olarak çalışmaktadır.
2016 yılından beri de İstanbul Bilgi Üniversitesi SMYO Radyoterapi bölümünde Prof. kadrosunda ders vermektedir.
22